コンテンツへスキップ
Merck

250A-1

Sigma-Aldrich

Factor VIII-R Ag. Rabbit Polyclonal Antibody

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
12352203
NACRES:
NA.41

由来生物

rabbit

品質水準

100
500

結合体

unconjugated

抗体製品の状態

Ig fraction of antiserum

抗体製品タイプ

primary antibodies

クローン

polyclonal

詳細

For In Vitro Diagnostic Use in Select Regions (See Chart)

形状

buffered aqueous solution

化学種の反応性

human

包装

vial of 0.1 mL concentrate (250A-14)
vial of 0.5 mL concentrate (250A-15)
bottle of 1.0 mL predilute (250A-17)
vial of 1.0 mL concentrate (250A-16)
bottle of 7.0 mL predilute (250A-18)

メーカー/製品名

Cell Marque

テクニック

immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:10-1:50

コントロール

placenta

輸送温度

wet ice

保管温度

2-8°C

視覚化

cytoplasmic

遺伝子情報

human ... VWF(7450)

関連するカテゴリー

詳細

Factor VIII-Related Antigen or von Willebrand factor is a glycoprotein associated with hemostasis in promoting the adhesion of platelets. Anti-Factor VIII Related Antigen reactivity is seen in endothelial cells, hemangioma, and the majority of tumors of endothelial origin such as Kaposi’s sarcoma and angiosarcoma.

品質


IVD

IVD

IVD

RUO

関連事項

Factor VIII-R Ag. (polyclonal) Positive Control Slides, Product No. 250S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).

物理的形状

Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide

調製ノート

Download the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.

その他情報

For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com

法的情報

Cell Marque is a trademark of Merck KGaA, Darmstadt, Germany

Not finding the right product?  

Try our 製品選択ツール.


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

J Ansell et al.
Cancer, 50(8), 1506-1512 (1982-10-15)
The case history of a patient with diffuse histiocytic lymphoma and skin lesions characteristic of malignant angioendotheliomatosis is reported. The patient initially responded to aggressive chemotherapy but quickly had a relapse, CNS disease developed, and the patient died one year
K H Fulling et al.
Cancer, 51(6), 1107-1118 (1983-03-15)
Two cases of neoplastic angioendotheliomatosis are described. Both patients presented with subacute development of dementia punctuated by focal neurologic signs. Postmortem examination in both cases disclosed a vasculocentric distribution of neoplastic cells in many organs. Two characteristic histologic patterns were
X W Bian et al.
Analytical and quantitative cytology and histology, 22(3), 267-274 (2000-06-29)
To investigate the correlation of angiogenic factor expression levels with the degrees of malignancy and vascularity and their clinicopathologic significance in astrocytomas. Factor VIII-related antigen (FVIII-RAg) was used as the marker of endothelia and basic fibroblast growth factor (bFGF); FGF
U K Zätterström et al.
Head & neck, 17(4), 312-318 (1995-07-01)
The progression of tumor growth requires the recruitment of new blood vessels. It has been suggested that the degree of neovascularization would correlate with clinical prognosis. The purpose of the present study was to ascertain whether tumor vascularization correlated with
J Bhawan et al.
Cancer, 55(3), 570-576 (1985-02-01)
A patient was diagnosed as having angioendotheliomatosis proliferans systemisata (APS) based on characteristic clinical and histologic features. A few days later, malignant lymphoma involving the gut was discovered. Immunohistochemical and electronmicroscopic studies confirmed the nonendothelial and lymphoid nature of intravascular

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)